Report banner
Home
Industries
Healthcare
Theranostics Market
Updated On

Jan 18 2025

Total Pages

192

Market
Insights

7,500+

Reports delivered globally, covering a wide range of industries and sectors.

2,350+

Clients who trust our expertise and rely on our insights for business decisions.

1,050+

Managed Reports, ensuring seamless updates and premium service.

100%

Satisfied Customers, committed to delivering exceptional value and quality.

Theranostics Market Decade Long Trends, Analysis and Forecast 2025-2033

Theranostics Market by Product (Diagnostic imaging, Radiopharmaceuticals, IVD/Biomarker screeening, Software and services), by Application (Prostate cancer, Bone metastasis, Neuroendocrine tumors, Lymphoma, Cardiovascular diseases, Other applications), by End-use (Hospitals, Diagnostics centers, Specialty clinics, Other end-users), by North America (U.S., Canada), by Europe (Germany, UK, France, Spain, Italy, Rest of Europe), by Asia Pacific (Japan, China, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Argentina, Mexico, Rest of Latin America), by Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa) Forecast 2025-2033

Main Logo

Theranostics Market Decade Long Trends, Analysis and Forecast 2025-2033

Key Insights

The size of the Theranostics market was valued at USD XXX Billion in 2023 and is projected to reach USD XXX Billion by 2032, with an expected CAGR of 13.6% during the forecast period.Theranostics is a rather emerging field within medicine, including diagnostics and treatments under one approach. This will make it all possible to try personalizing healthcare treatment for patient individuality-disease biology; genetic makeup as well as differential treatment response-from this point alone, theranostics seems to be really powerful because once diagnosis and appropriate therapeutic modalities are combined with it, target diseased tissue in the individual and monitor progress with real time monitoring of progression to adjust optimized treatment plans within that patient. This approach holds promise for improving outcomes in many diseases, including cancers, cardiovascular diseases, and autoimmune disorders.   

Theranostics Market Research Report - Market Size, Growth & Forecast

Theranostics Market Concentration & Characteristics

The Theranostics Market exhibits a moderate level of concentration, with the leading players accounting for a significant market share. Intense competition characterizes the industry, with players focusing on innovation and strategic partnerships to gain a competitive edge. The market is also subject to stringent regulatory oversight, which can impact the approval and commercialization of theranostic products. End-user concentration is observed within hospitals and diagnostic centers, while M&A activity is prevalent as companies seek to expand their market reach and product portfolios.

Theranostics Market Trends

Precision Medicine: Theranostics plays a transformative role in precision medicine, enabling tailored treatment plans based on an individual's genetic and molecular profile. This approach enhances treatment efficacy and reduces adverse effects.

Radiopharmaceutical Advancements: The development of novel radiopharmaceuticals with improved specificity and efficacy is driving market growth. These advancements facilitate more precise diagnosis and treatment of various diseases.

Chronic Disease Prevalence: The rising prevalence of chronic diseases such as cancer and cardiovascular diseases is fueling the need for theranostic approaches that offer improved patient outcomes and reduced healthcare costs.

Theranostics Market Growth

Key Region or Country & Segment to Dominate the Market

North America: The region is expected to retain its dominance in the Theranostics Market due to the presence of well-established healthcare infrastructure, high investment in R&D, and a large patient population.

Diagnostic Imaging: This segment is projected to hold the largest market share, driven by the increasing adoption of advanced imaging techniques such as PET and MRI, which provide detailed anatomical and molecular information.

Theranostics Market Product Insights Report Coverage & Deliverables

This report provides comprehensive insights into the Theranostics Market and includes the following deliverables:

  • Market size and growth projections
  • Market segmentation analysis (product, application, end-use)
  • Competitive landscape assessment
  • Key market trends and drivers
  • Market challenges and restraints

Theranostics Market Analysis

The Theranostics Market witnessed steady expansion in recent years and is poised for significant growth in the coming years. The market size is expected to grow from 2.2 Billion in 2022 to 5.6 Billion by 2030, exhibiting a CAGR of 13.6%. The growth is attributed to rising healthcare expenditure, increased demand for personalized treatment, and technological advancements.

Theranostics Market Regional Insights

  • North America: 40% Market Share
  • Europe: 28% Market Share
  • Asia-Pacific: 22% Market Share
  • Latin America: 6% Market Share
  • Middle East and Africa: 4% Market Share

Driving Forces: What's Propelling the Theranostics Market

  • Precision medicine advancements
  • Government initiatives
  • Rising chronic disease prevalence
  • Technological advancements

Challenges and Restraints in Theranostics Market

  • High cost of theranostic procedures
  • Regulatory barriers
  • Lack of reimbursement policies
  • Limited access to diagnostic facilities

Emerging Trends in Theranostics Market

  • Artificial Intelligence (AI) in theranostics
  • Theranostics for personalized drug development
  • Theranostics in regenerative medicine

Theranostics Industry News

  • September 2023: GE Healthcare and Mayo Clinic collaborate on medical imaging and theranostics research and development.
  • November 2023: Bayer and Broad Institute extend partnership in cancer target identification and oncology therapies.

Leading Players in the Theranostics Market Keyword

  • Bayer AG
  • Beckman Coulter, Inc.
  • Cardinal Health, Inc.
  • Canon Medical Systems Corporation
  • Curium
  • F. Hoffmann La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Lantheus Holdings, Inc.
  • Siemens Healthnieers AG
  • Thermo Fisher Scientific Inc.

Theranostics Market Segmentation

1. Product

  • 1.1. Diagnostic imaging
    • 1.1.1. MRI
    • 1.1.2. PET imaging
    • 1.1.3. Nuclear imaging
    • 1.1.4. CT scan
    • 1.1.5. Molecular imaging
    • 1.1.6. Other diagnostic imaging
  • 1.2. Radiopharmaceuticals
    • 1.2.1. Lutetium-177
    • 1.2.2. Samarium-153
    • 1.2.3. Radium-223
    • 1.2.4. Iodine-131
    • 1.2.5. Yttrium-90
    • 1.2.6. Gallium-68
    • 1.2.7. Fluorine-18
    • 1.2.8. Other radiopharmaceuticals
  • 1.3. IVD/Biomarker screeening
    • 1.3.1. Polymerase chain reaction (PCR)
    • 1.3.2. Next-generation sequencing (NGS)
    • 1.3.3. Fluorescence in-situ hybridization (FISH)
  • 1.4. Software and services

2. Application

  • 2.1. Prostate cancer
  • 2.2. Bone metastasis
  • 2.3. Neuroendocrine tumors
  • 2.4. Lymphoma
  • 2.5. Cardiovascular diseases
  • 2.6. Other applications

3. End-use

  • 3.1. Hospitals
  • 3.2. Diagnostics centers
  • 3.3. Specialty clinics
  • 3.4. Other end-users

Theranostics Market Segmentation By Geography

1. North America

  • 1.1. U.S.
  • 1.2. Canada

2. Europe

  • 2.1. Germany
  • 2.2. UK
  • 2.3. France
  • 2.4. Spain
  • 2.5. Italy
  • 2.6. Rest of Europe

3. Asia Pacific

  • 3.1. Japan
  • 3.2. China
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific

4. Latin America

  • 4.1. Brazil
  • 4.2. Argentina
  • 4.3. Mexico
  • 4.4. Rest of Latin America

5. Middle East and Africa

  • 5.1. South Africa
  • 5.2. Saudi Arabia
  • 5.3. UAE
  • 5.4. Rest of Middle East and Africa

Theranostics Market Regional Share

Theranostics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 13.6% from 2019-2033
Segmentation
    • By Product
      • Diagnostic imaging
        • MRI
        • PET imaging
        • Nuclear imaging
        • CT scan
        • Molecular imaging
        • Other diagnostic imaging
      • Radiopharmaceuticals
        • Lutetium-177
        • Samarium-153
        • Radium-223
        • Iodine-131
        • Yttrium-90
        • Gallium-68
        • Fluorine-18
        • Other radiopharmaceuticals
      • IVD/Biomarker screeening
        • Polymerase chain reaction (PCR)
        • Next-generation sequencing (NGS)
        • Fluorescence in-situ hybridization (FISH)
      • Software and services
    • By Application
      • Prostate cancer
      • Bone metastasis
      • Neuroendocrine tumors
      • Lymphoma
      • Cardiovascular diseases
      • Other applications
    • By End-use
      • Hospitals
      • Diagnostics centers
      • Specialty clinics
      • Other end-users
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1 Growing geriatric population
        • 3.2.2 Rising prevalence of targeted diseases
        • 3.2.3 Technological advancement in theranostics
        • 3.2.4 Growing focus on precision medicine
      • 3.3. Market Restrains
        • 3.3.1 Limited duration of activity exhibited by radiopharmaceuticals
        • 3.3.2 Lack of favourable reimbursement scenario
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Product
      • 5.1.1. Diagnostic imaging
        • 5.1.1.1. MRI
        • 5.1.1.2. PET imaging
        • 5.1.1.3. Nuclear imaging
        • 5.1.1.4. CT scan
        • 5.1.1.5. Molecular imaging
        • 5.1.1.6. Other diagnostic imaging
      • 5.1.2. Radiopharmaceuticals
        • 5.1.2.1. Lutetium-177
        • 5.1.2.2. Samarium-153
        • 5.1.2.3. Radium-223
        • 5.1.2.4. Iodine-131
        • 5.1.2.5. Yttrium-90
        • 5.1.2.6. Gallium-68
        • 5.1.2.7. Fluorine-18
        • 5.1.2.8. Other radiopharmaceuticals
      • 5.1.3. IVD/Biomarker screeening
        • 5.1.3.1. Polymerase chain reaction (PCR)
        • 5.1.3.2. Next-generation sequencing (NGS)
        • 5.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 5.1.4. Software and services
    • 5.2. Market Analysis, Insights and Forecast - by Application
      • 5.2.1. Prostate cancer
      • 5.2.2. Bone metastasis
      • 5.2.3. Neuroendocrine tumors
      • 5.2.4. Lymphoma
      • 5.2.5. Cardiovascular diseases
      • 5.2.6. Other applications
    • 5.3. Market Analysis, Insights and Forecast - by End-use
      • 5.3.1. Hospitals
      • 5.3.2. Diagnostics centers
      • 5.3.3. Specialty clinics
      • 5.3.4. Other end-users
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. Middle East and Africa
  6. 6. North America Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 6.1. Market Analysis, Insights and Forecast - by Product
      • 6.1.1. Diagnostic imaging
        • 6.1.1.1. MRI
        • 6.1.1.2. PET imaging
        • 6.1.1.3. Nuclear imaging
        • 6.1.1.4. CT scan
        • 6.1.1.5. Molecular imaging
        • 6.1.1.6. Other diagnostic imaging
      • 6.1.2. Radiopharmaceuticals
        • 6.1.2.1. Lutetium-177
        • 6.1.2.2. Samarium-153
        • 6.1.2.3. Radium-223
        • 6.1.2.4. Iodine-131
        • 6.1.2.5. Yttrium-90
        • 6.1.2.6. Gallium-68
        • 6.1.2.7. Fluorine-18
        • 6.1.2.8. Other radiopharmaceuticals
      • 6.1.3. IVD/Biomarker screeening
        • 6.1.3.1. Polymerase chain reaction (PCR)
        • 6.1.3.2. Next-generation sequencing (NGS)
        • 6.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 6.1.4. Software and services
    • 6.2. Market Analysis, Insights and Forecast - by Application
      • 6.2.1. Prostate cancer
      • 6.2.2. Bone metastasis
      • 6.2.3. Neuroendocrine tumors
      • 6.2.4. Lymphoma
      • 6.2.5. Cardiovascular diseases
      • 6.2.6. Other applications
    • 6.3. Market Analysis, Insights and Forecast - by End-use
      • 6.3.1. Hospitals
      • 6.3.2. Diagnostics centers
      • 6.3.3. Specialty clinics
      • 6.3.4. Other end-users
  7. 7. Europe Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 7.1. Market Analysis, Insights and Forecast - by Product
      • 7.1.1. Diagnostic imaging
        • 7.1.1.1. MRI
        • 7.1.1.2. PET imaging
        • 7.1.1.3. Nuclear imaging
        • 7.1.1.4. CT scan
        • 7.1.1.5. Molecular imaging
        • 7.1.1.6. Other diagnostic imaging
      • 7.1.2. Radiopharmaceuticals
        • 7.1.2.1. Lutetium-177
        • 7.1.2.2. Samarium-153
        • 7.1.2.3. Radium-223
        • 7.1.2.4. Iodine-131
        • 7.1.2.5. Yttrium-90
        • 7.1.2.6. Gallium-68
        • 7.1.2.7. Fluorine-18
        • 7.1.2.8. Other radiopharmaceuticals
      • 7.1.3. IVD/Biomarker screeening
        • 7.1.3.1. Polymerase chain reaction (PCR)
        • 7.1.3.2. Next-generation sequencing (NGS)
        • 7.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 7.1.4. Software and services
    • 7.2. Market Analysis, Insights and Forecast - by Application
      • 7.2.1. Prostate cancer
      • 7.2.2. Bone metastasis
      • 7.2.3. Neuroendocrine tumors
      • 7.2.4. Lymphoma
      • 7.2.5. Cardiovascular diseases
      • 7.2.6. Other applications
    • 7.3. Market Analysis, Insights and Forecast - by End-use
      • 7.3.1. Hospitals
      • 7.3.2. Diagnostics centers
      • 7.3.3. Specialty clinics
      • 7.3.4. Other end-users
  8. 8. Asia Pacific Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 8.1. Market Analysis, Insights and Forecast - by Product
      • 8.1.1. Diagnostic imaging
        • 8.1.1.1. MRI
        • 8.1.1.2. PET imaging
        • 8.1.1.3. Nuclear imaging
        • 8.1.1.4. CT scan
        • 8.1.1.5. Molecular imaging
        • 8.1.1.6. Other diagnostic imaging
      • 8.1.2. Radiopharmaceuticals
        • 8.1.2.1. Lutetium-177
        • 8.1.2.2. Samarium-153
        • 8.1.2.3. Radium-223
        • 8.1.2.4. Iodine-131
        • 8.1.2.5. Yttrium-90
        • 8.1.2.6. Gallium-68
        • 8.1.2.7. Fluorine-18
        • 8.1.2.8. Other radiopharmaceuticals
      • 8.1.3. IVD/Biomarker screeening
        • 8.1.3.1. Polymerase chain reaction (PCR)
        • 8.1.3.2. Next-generation sequencing (NGS)
        • 8.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 8.1.4. Software and services
    • 8.2. Market Analysis, Insights and Forecast - by Application
      • 8.2.1. Prostate cancer
      • 8.2.2. Bone metastasis
      • 8.2.3. Neuroendocrine tumors
      • 8.2.4. Lymphoma
      • 8.2.5. Cardiovascular diseases
      • 8.2.6. Other applications
    • 8.3. Market Analysis, Insights and Forecast - by End-use
      • 8.3.1. Hospitals
      • 8.3.2. Diagnostics centers
      • 8.3.3. Specialty clinics
      • 8.3.4. Other end-users
  9. 9. Latin America Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 9.1. Market Analysis, Insights and Forecast - by Product
      • 9.1.1. Diagnostic imaging
        • 9.1.1.1. MRI
        • 9.1.1.2. PET imaging
        • 9.1.1.3. Nuclear imaging
        • 9.1.1.4. CT scan
        • 9.1.1.5. Molecular imaging
        • 9.1.1.6. Other diagnostic imaging
      • 9.1.2. Radiopharmaceuticals
        • 9.1.2.1. Lutetium-177
        • 9.1.2.2. Samarium-153
        • 9.1.2.3. Radium-223
        • 9.1.2.4. Iodine-131
        • 9.1.2.5. Yttrium-90
        • 9.1.2.6. Gallium-68
        • 9.1.2.7. Fluorine-18
        • 9.1.2.8. Other radiopharmaceuticals
      • 9.1.3. IVD/Biomarker screeening
        • 9.1.3.1. Polymerase chain reaction (PCR)
        • 9.1.3.2. Next-generation sequencing (NGS)
        • 9.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 9.1.4. Software and services
    • 9.2. Market Analysis, Insights and Forecast - by Application
      • 9.2.1. Prostate cancer
      • 9.2.2. Bone metastasis
      • 9.2.3. Neuroendocrine tumors
      • 9.2.4. Lymphoma
      • 9.2.5. Cardiovascular diseases
      • 9.2.6. Other applications
    • 9.3. Market Analysis, Insights and Forecast - by End-use
      • 9.3.1. Hospitals
      • 9.3.2. Diagnostics centers
      • 9.3.3. Specialty clinics
      • 9.3.4. Other end-users
  10. 10. Middle East and Africa Theranostics Market Analysis, Insights and Forecast, 2019-2031
    • 10.1. Market Analysis, Insights and Forecast - by Product
      • 10.1.1. Diagnostic imaging
        • 10.1.1.1. MRI
        • 10.1.1.2. PET imaging
        • 10.1.1.3. Nuclear imaging
        • 10.1.1.4. CT scan
        • 10.1.1.5. Molecular imaging
        • 10.1.1.6. Other diagnostic imaging
      • 10.1.2. Radiopharmaceuticals
        • 10.1.2.1. Lutetium-177
        • 10.1.2.2. Samarium-153
        • 10.1.2.3. Radium-223
        • 10.1.2.4. Iodine-131
        • 10.1.2.5. Yttrium-90
        • 10.1.2.6. Gallium-68
        • 10.1.2.7. Fluorine-18
        • 10.1.2.8. Other radiopharmaceuticals
      • 10.1.3. IVD/Biomarker screeening
        • 10.1.3.1. Polymerase chain reaction (PCR)
        • 10.1.3.2. Next-generation sequencing (NGS)
        • 10.1.3.3. Fluorescence in-situ hybridization (FISH)
      • 10.1.4. Software and services
    • 10.2. Market Analysis, Insights and Forecast - by Application
      • 10.2.1. Prostate cancer
      • 10.2.2. Bone metastasis
      • 10.2.3. Neuroendocrine tumors
      • 10.2.4. Lymphoma
      • 10.2.5. Cardiovascular diseases
      • 10.2.6. Other applications
    • 10.3. Market Analysis, Insights and Forecast - by End-use
      • 10.3.1. Hospitals
      • 10.3.2. Diagnostics centers
      • 10.3.3. Specialty clinics
      • 10.3.4. Other end-users
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2024
      • 11.2. Company Profiles
        • 11.2.1 Bayer AG
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Beckman Coulter Inc.
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Cardinal Health Inc.
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Canon Medical Systems Corporation
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Curium
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 F. Hoffmann La Roche Ltd.
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 GE HealthCare Technologies Inc.
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Koninklijke Philips N.V.
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Lantheus Holdings Inc.
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Siemens Healthnieers AG
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
        • 11.2.11 Thermo Fisher Scientific Inc.
          • 11.2.11.1. Overview
          • 11.2.11.2. Products
          • 11.2.11.3. SWOT Analysis
          • 11.2.11.4. Recent Developments
          • 11.2.11.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Theranostics Market Revenue Breakdown (Billion, %) by Region 2024 & 2032
  2. Figure 2: North America Theranostics Market Revenue (Billion), by Product 2024 & 2032
  3. Figure 3: North America Theranostics Market Revenue Share (%), by Product 2024 & 2032
  4. Figure 4: North America Theranostics Market Revenue (Billion), by Application 2024 & 2032
  5. Figure 5: North America Theranostics Market Revenue Share (%), by Application 2024 & 2032
  6. Figure 6: North America Theranostics Market Revenue (Billion), by End-use 2024 & 2032
  7. Figure 7: North America Theranostics Market Revenue Share (%), by End-use 2024 & 2032
  8. Figure 8: North America Theranostics Market Revenue (Billion), by Country 2024 & 2032
  9. Figure 9: North America Theranostics Market Revenue Share (%), by Country 2024 & 2032
  10. Figure 10: Europe Theranostics Market Revenue (Billion), by Product 2024 & 2032
  11. Figure 11: Europe Theranostics Market Revenue Share (%), by Product 2024 & 2032
  12. Figure 12: Europe Theranostics Market Revenue (Billion), by Application 2024 & 2032
  13. Figure 13: Europe Theranostics Market Revenue Share (%), by Application 2024 & 2032
  14. Figure 14: Europe Theranostics Market Revenue (Billion), by End-use 2024 & 2032
  15. Figure 15: Europe Theranostics Market Revenue Share (%), by End-use 2024 & 2032
  16. Figure 16: Europe Theranostics Market Revenue (Billion), by Country 2024 & 2032
  17. Figure 17: Europe Theranostics Market Revenue Share (%), by Country 2024 & 2032
  18. Figure 18: Asia Pacific Theranostics Market Revenue (Billion), by Product 2024 & 2032
  19. Figure 19: Asia Pacific Theranostics Market Revenue Share (%), by Product 2024 & 2032
  20. Figure 20: Asia Pacific Theranostics Market Revenue (Billion), by Application 2024 & 2032
  21. Figure 21: Asia Pacific Theranostics Market Revenue Share (%), by Application 2024 & 2032
  22. Figure 22: Asia Pacific Theranostics Market Revenue (Billion), by End-use 2024 & 2032
  23. Figure 23: Asia Pacific Theranostics Market Revenue Share (%), by End-use 2024 & 2032
  24. Figure 24: Asia Pacific Theranostics Market Revenue (Billion), by Country 2024 & 2032
  25. Figure 25: Asia Pacific Theranostics Market Revenue Share (%), by Country 2024 & 2032
  26. Figure 26: Latin America Theranostics Market Revenue (Billion), by Product 2024 & 2032
  27. Figure 27: Latin America Theranostics Market Revenue Share (%), by Product 2024 & 2032
  28. Figure 28: Latin America Theranostics Market Revenue (Billion), by Application 2024 & 2032
  29. Figure 29: Latin America Theranostics Market Revenue Share (%), by Application 2024 & 2032
  30. Figure 30: Latin America Theranostics Market Revenue (Billion), by End-use 2024 & 2032
  31. Figure 31: Latin America Theranostics Market Revenue Share (%), by End-use 2024 & 2032
  32. Figure 32: Latin America Theranostics Market Revenue (Billion), by Country 2024 & 2032
  33. Figure 33: Latin America Theranostics Market Revenue Share (%), by Country 2024 & 2032
  34. Figure 34: Middle East and Africa Theranostics Market Revenue (Billion), by Product 2024 & 2032
  35. Figure 35: Middle East and Africa Theranostics Market Revenue Share (%), by Product 2024 & 2032
  36. Figure 36: Middle East and Africa Theranostics Market Revenue (Billion), by Application 2024 & 2032
  37. Figure 37: Middle East and Africa Theranostics Market Revenue Share (%), by Application 2024 & 2032
  38. Figure 38: Middle East and Africa Theranostics Market Revenue (Billion), by End-use 2024 & 2032
  39. Figure 39: Middle East and Africa Theranostics Market Revenue Share (%), by End-use 2024 & 2032
  40. Figure 40: Middle East and Africa Theranostics Market Revenue (Billion), by Country 2024 & 2032
  41. Figure 41: Middle East and Africa Theranostics Market Revenue Share (%), by Country 2024 & 2032
List of Tables
  1. Table 1: Global Theranostics Market Revenue Billion Forecast, by Region 2019 & 2032
  2. Table 2: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  3. Table 3: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  4. Table 4: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  5. Table 5: Global Theranostics Market Revenue Billion Forecast, by Region 2019 & 2032
  6. Table 6: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  7. Table 7: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  8. Table 8: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  9. Table 9: Global Theranostics Market Revenue Billion Forecast, by Country 2019 & 2032
  10. Table 10: U.S. Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  11. Table 11: Canada Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  12. Table 12: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  13. Table 13: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  14. Table 14: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  15. Table 15: Global Theranostics Market Revenue Billion Forecast, by Country 2019 & 2032
  16. Table 16: Germany Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  17. Table 17: UK Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  18. Table 18: France Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  19. Table 19: Spain Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  20. Table 20: Italy Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  21. Table 21: Rest of Europe Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  22. Table 22: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  23. Table 23: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  24. Table 24: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  25. Table 25: Global Theranostics Market Revenue Billion Forecast, by Country 2019 & 2032
  26. Table 26: Japan Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  27. Table 27: China Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  28. Table 28: India Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  29. Table 29: Australia Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  30. Table 30: South Korea Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  31. Table 31: Rest of Asia Pacific Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  32. Table 32: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  33. Table 33: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  34. Table 34: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  35. Table 35: Global Theranostics Market Revenue Billion Forecast, by Country 2019 & 2032
  36. Table 36: Brazil Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  37. Table 37: Argentina Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  38. Table 38: Mexico Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  39. Table 39: Rest of Latin America Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  40. Table 40: Global Theranostics Market Revenue Billion Forecast, by Product 2019 & 2032
  41. Table 41: Global Theranostics Market Revenue Billion Forecast, by Application 2019 & 2032
  42. Table 42: Global Theranostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  43. Table 43: Global Theranostics Market Revenue Billion Forecast, by Country 2019 & 2032
  44. Table 44: South Africa Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  45. Table 45: Saudi Arabia Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  46. Table 46: UAE Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  47. Table 47: Rest of Middle East and Africa Theranostics Market Revenue (Billion) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

Get a Free Sample

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Pricing

$4,850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
$5,350
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$8,350
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
avatar

Director of Business Development

Sarah L

The insights provided in this report were spot-on and exactly what we needed to guide our strategic planning. The level of detail on industry trends and forecasts is unmatched. It saved us countless hours and gave us a significant advantage!"

Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1

About Market Insights Report

Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.

Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.

+1 2315155523

sales@marketinsights.report

  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
sales@marketinsights.report

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

sales@marketinsights.report

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingAutomotiveHealthcareAgricultureConstructionEnergy & PowerFood & BeverageMedia & TechnologyAerospace & DefenseIndustrial MachineryChemicals & MaterialsProfessional ServicesAnimal Health & NutritionConsumer Goods and ServicesSemiconductors & Electronics

© 2025 AMA Research. All rights reserved

Testimonials
Privacy Policy
Terms and Conditions
FAQ

Related Reports

See the similar reports

report thumbnailUrinary Tract Infection Testing Market

Urinary Tract Infection Testing Market 2025 Market Trends and 2033 Forecasts: Exploring Growth Potential

report thumbnailAllergy Diagnostics Market

Allergy Diagnostics Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

report thumbnailOphthalmology Diagnostics Market

Ophthalmology Diagnostics Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailHepatitis Diagnostic Tests Market

Hepatitis Diagnostic Tests Market Soars to 3.4 Billion , witnessing a CAGR of 5.8 during the forecast period 2025-2033

report thumbnailMedical Camera Market

Medical Camera Market Size, Share, and Growth Report: In-Depth Analysis and Forecast to 2033"

report thumbnailE-pharmacy Market

E-pharmacy Market 2025-2033 Trends and Competitor Dynamics: Unlocking Growth Opportunities

report thumbnailInterventional Cardiology & Peripheral Vascular Devices Market

Interventional Cardiology & Peripheral Vascular Devices Market Growth Opportunities and Market Forecast 2025-2033: A Strategic Analysis

report thumbnailOrthodontic Supplies Market

Orthodontic Supplies Market 2025-2033 Trends and Competitor Dynamics: Unlocking Growth Opportunities

report thumbnailDefibrillators Market

Defibrillators Market Soars to 11 billion, witnessing a CAGR of 6.9 during the forecast period 2025-2033

report thumbnailSleep Disorder Market

Sleep Disorder Market 12 CAGR Growth Outlook 2025-2033

report thumbnailAutoinjectors Market

Autoinjectors Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

report thumbnailProteomics Market

Proteomics Market 2025 to Grow at 10 CAGR with 46.5 Billion Market Size: Analysis and Forecasts 2033

report thumbnailMammography Systems Market

Mammography Systems Market Decade Long Trends, Analysis and Forecast 2025-2033

report thumbnailSleep Apnea Devices Market

Sleep Apnea Devices Market Is Set To Reach 7.5 Billion By 2033, Growing At A CAGR Of 7.5

report thumbnailJoint Pain Injections Market

Joint Pain Injections Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

report thumbnailBreast Pump Market

Breast Pump Market Strategic Roadmap: Analysis and Forecasts 2025-2033

report thumbnailElectrophysiology Market

Electrophysiology Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailDisposable Incontinence Products Market

Disposable Incontinence Products Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

report thumbnailMagnetoencephalography Market

Magnetoencephalography Market 2025 to Grow at 11.4 CAGR with 174.9 Million Market Size: Analysis and Forecasts 2033

report thumbnailOncology Market

Oncology Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033